TITLE

Cost to develop new biotech drug: $1.2 billion

PUB. DATE
January 2007
SOURCE
Pharmaceutical Representative;Jan2007, Vol. 37 Issue 1, p12
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that the average cost of developing a new biotechnology drug is 1.2 billion dollars in the U.S. This is according to the Tufts Center for the Study of Drug Development in Boston, Massachusetts. The estimate reflects expenses associated with failed drug candidates. It is based on compound-specific costs for 17 investigational biopharmaceuticals.
ACCESSION #
23620463

 

Related Articles

  • Bush Backs Competitive Pharmaceutical Market as Key to Innovation.  // Applied Clinical Trials;Sep2002, Vol. 11 Issue 9, p22 

    Presents a report from the U.S. Department of Health and Human Services that documents the importance of new drug and biotechnology research and development in improving the health of the elderly. Examples of restrictions on patient access to newer drugs in countries that rely on government...

  • Every conceivable angle. Trim, Steve // Laboratory News;Sep2015, p22 

    The article focuses on the challenges on drug discovery and development by small biotechnology companies and big pharmaceutical firms in several fields such as microbiology and chemotherapy.

  • Most Majors Still Looking for Biotech Breakthrough.  // Chemical Market Reporter;4/12/2004, Vol. 265 Issue 15, p10 

    Reports that biotechnology-based medicines are playing an increasingly important role in the global pharmaceutical market. Absence of biotechnology drugs from the portfolio of major pharmaceutical companies; Revenues from the sale of biotechnology drugs.

  • Sector's rude health boosts trust. CUMMING, SHAUN // Fund Strategy;11/14/2011, p32 

    The article discusses the bullish prospects of the biotechnology sector in the U.S. It states that International Biotechnology Trust manager David Pinniger has expressed confidence on the sector's ability to outperform the market in the long-term. Pinniger attributes his insight to the rapidly...

  • Building biotechnology in India - Drugs are not the answer.  // Journal of Commercial Biotechnology;Mar2014, Vol. 20 Issue 2, p3 

    An introduction is presented in which the editor discusses various reports within the issue on topics including pharmaceutical globalization, Indian biotechnology industry and novel drug development.

  • BioCrossroads: It can happen here. Wall, J. K. // Indianapolis Business Journal;2/4/2008, Vol. 28 Issue 49, p1A 

    The article reports on BioCrossroads' issuance of a report that attempts to show in detail the vast market opportunity they see in the drug industry. The report was written by the company three months after launching an initiative to boost drug-development firms in Indiana. BioCrossroads' report...

  • Advances in Microarrays and Their Applications. Pickering, Lulu // Drug Discovery & Development;Feb2003, Vol. 6 Issue 2, p39 

    Focuses on innovations in DNA chip-based microarrays and their applications in the pharmaceutical industry's drug development. DNA microarray and chemistry technologies developed by NimbleGen Systems Inc. based on its Maskless Array Synthesizer technology; Single Molecule Array technology...

  • A Major Force in Biotechnology Sweden. Williams, Ylva // BioPharm International;Jan2004, Vol. 17 Issue 1, p57 

    Focuses on the growth of biotechnology for pharmaceutical industry in Sweden. Presence of world-class pharmaceutical companies in the country; Compliance with the basic requirements for the use of biotechnology; Collaborations in the discovery and drug development process.

  • The Lottery. Clinton, Patrick // Pharmaceutical Executive;May2008, Vol. 28 Issue 5, p12 

    The article offers information on the biotech company engaged in drug development owned by Duane Roth in California. It presents Roth's views on the benefits of great deals from high technology entrepreneurs to biotech and pharmaceutical companies. Roth aims to encourage scientist entrepreneurs...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics